Related Experiment Video
Updated: Apr 23, 2026

09:12
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
9.3K
Host immunity to Clostridium difficile PCR ribotype 017 strains
Nazila V Jafari1, Mario Songane1, Richard A Stabler2
1Infection, Immunity, Inflammation and Physiological Medicine Programme, Institute of Child Health, University College London, London, United Kingdom.
Infection and Immunity
|September 17, 2014
Summary
Clostridium difficile strains elicit distinct immune responses. Understanding these differences in host immunity is crucial for developing effective treatments against this nosocomial pathogen.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Clostridium difficile is a major cause of hospital-acquired infections and antibiotic-associated diarrhea.
- While hypervirulent RT027 strains are well-studied, the pathogenesis of RT017 strains remains less understood.
- This study focuses on characterizing host immune responses to two specific RT017 strains, CF5 and M68.
Purpose of the Study:
- To compare the host immune responses elicited by two distinct Clostridium difficile RT017 strains, CF5 and M68.
- To investigate the engagement of these strains with host pattern recognition receptors.
- To analyze the resulting dendritic cell (DC) and T cell (Th1/Th17) cytokine profiles.
Main Methods:
- Utilized a model cell line to assess TLR2/6, TLR2-CD14, and TLR5 engagement.
- Measured DC cytokine production (IL-12, IL-27, IL-10, IL-1β) after co-culture with C. difficile strains.
- Analyzed T cell responses (Th1 and Th17) and ex vivo human gastrointestinal cytokine profiles.
Main Results:
- Both CF5 and M68 engaged similarly with TLRs, but CF5 induced higher levels of IL-12, IL-27, and IL-10 in DCs.
- M68, but not CF5, significantly increased secretory IL-1β, despite similar mRNA levels.
- CF5 promoted balanced Th1/Th17 responses, whereas M68 skewed towards Th17 immunity.
Conclusions:
- Clostridium difficile strains induce overlapping yet distinct mucosal and DC/T cell immune responses.
- Toxin-mediated IL-1β release is a key factor in C. difficile pathogenesis.
- Targeting the IL-1β cytokine axis presents a potential therapeutic strategy for C. difficile infections.

